Exact Sciences
EXAS
#1146
Rank
ยฃ14.93 B
Marketcap
ยฃ78.23
Share price
0.00%
Change (1 day)
131.35%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total assets

Total assets on the balance sheet as of December 2025 : ยฃ4.37 Billion

According to Exact Sciences's latest financial reports the company's total assets are ยฃ4.37 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Exact Sciences - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2025-12-31ยฃ4.35 B-7.88%
2024-12-31ยฃ4.72 B-7%
2023-12-31ยฃ5.07 B-1.31%
2022-12-31ยฃ5.14 B3.93%
2021-12-31ยฃ4.95 B37.06%
2020-12-31ยฃ3.61 B35.15%
2019-12-31ยฃ2.67 B122.68%
2018-12-31ยฃ1.20 B171.09%
2017-12-31ยฃ0.44 B44.94%
2016-12-31ยฃ0.30 B24.39%
2015-12-31ยฃ0.24 B22.26%
2014-12-31ยฃ0.20 B126.04%
2013-12-31ยฃ88.89 M28.14%
2012-12-31ยฃ69.36 M11.21%
2011-12-31ยฃ62.37 M-0.23%
2010-12-31ยฃ62.52 M292.6%
2009-12-31ยฃ15.92 M295.73%
2008-12-31ยฃ4.02 M-45.22%
2007-12-31ยฃ7.34 M-39.71%
2006-12-31ยฃ12.18 M-44.48%
2005-12-31ยฃ21.94 M-24.91%
2004-12-31ยฃ29.22 M50.75%
2003-12-31ยฃ19.38 M-37.93%
2002-12-31ยฃ31.23 M-28.22%
2001-12-31ยฃ43.52 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Sanofi
SNY
ยฃ111.08 B 2,441.74%๐Ÿ‡ซ๐Ÿ‡ท France
Veracyte
VCYT
ยฃ1.04 B-76.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
ยฃ0.54 B-87.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
ยฃ16.48 M-99.62%๐Ÿ‡บ๐Ÿ‡ธ USA